📋 Tender Overview
Opioids And Insulin Secretion: A New Avenue To Fight Type 2 Diabetes
On The Trail Of An Opioid Modulation Of Insulin Secretionobesity And Type 2 Diabetes Are Interrelated, Increasingly Common And A Significant Threat To Public Health. Improved Therapies Are Needed Yet A Lack Of Understanding Of Disease Pathology Has Hindered Therapy Development. Opioids Impact Glucose Metabolism, Which Can Alter The Risk Of Diabetes Development. The Eu-Funded Opio Project Will Investigate A Potential Role Of The Delta Opioid Receptor In Mediating The Metabolic Response To Opioids In Humans. Further, If The Delta Opioid Receptor Turns Out To Play A Direct Role In Modulating Insulin Secretion From The Pancreas, The Team Will Have A New Therapeutic Target To Combat Both Obesity And Type 2 Diabetes.
Funded Under
European Research Council (Erc)
Total Cost
€ 1 997 915,00
Eu Contribution
€ 1 997 915,00
Coordinated By
Institut National De La Sante Et De La Recherche Medicale
France
